Pneumocystis carinii pneumonia following discontinuation of primary prophylaxis despite highly active antiretroviral therapy

被引：1
|
作者：
Mammen-Tobin, A [1 ]
Monteiro, EF [1 ]
机构：
[1] Gen Infirm, Dept Genitourinary Med, Leeds LS1 3EX, W Yorkshire, England
来源：
INTERNATIONAL JOURNAL OF STD & AIDS | 2000年 / 11卷 / 01期
关键词：
primary prophylaxis; Pneumocystis carinii pneumonia; HIV; HAART;
D O I：
10.1258/0956462001914805
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [1] Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection
    Weverling, GJ
    Mocroft, A
    Ledergerber, B
    Kirk, O
    González-Lahoz, J
    Monforte, AD
    Proenca, R
    Phillips, AN
    Lundgren, JD
    Reiss, P
    [J]. LANCET, 1999, 353 (9161): : 1293 - 1298
  • [2] Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy
    Schneider, MME
    Borleffs, JCC
    Stolk, RP
    Jaspers, CAJJ
    Hoepelman, AIM
    [J]. LANCET, 1999, 353 (9148): : 201 - 203
  • [3] Pneumocystis carinii pneumonia recurrence in HIV patients on highly active antiretroviral therapy:: Secondary prophylaxis
    Abgrall, S
    Matheron, S
    Le Moing, V
    Dupont, C
    Costagliola, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (02) : 151 - 158
  • [4] A randomized trial of the discontinuation of primary and secondary prophylaxis against Pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection.
    de Quiros, JCLB
    Miro, JM
    Pena, JM
    Podzamczer, D
    Alberdi, JC
    Martínez, E
    Cosin, J
    Claramonte, X
    Gonzalez, J
    Domingo, P
    Casado, JL
    Ribera, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (03): : 159 - 167
  • [5] Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy
    Furrer, H
    Egger, M
    Opravil, M
    Bernasconi, E
    Hirschel, B
    Battegay, M
    Telenti, A
    Vernazza, PL
    Rickenbach, M
    Flepp, M
    Malinverni, R
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (17): : 1301 - 1306
  • [6] The continued occurrence of primary Pneumocystis carinii pneumonia despite the availability of prophylaxis
    Klein, MB
    Lalonde, RG
    [J]. CLINICAL INFECTIOUS DISEASES, 1997, 24 (03) : 522 - 523
  • [7] Pneumocystis carinii pneumonia after the discontinuation of secondary prophylaxis
    Degen, O
    ven Lunzen, J
    Horstkotte, MA
    Sobottka, I
    Stellbrink, HJ
    [J]. AIDS, 2002, 16 (10) : 1433 - 1434
  • [8] Discontinuation of secondary prophylaxis and the risk of Pneumocystis carinii pneumonia
    Miguez-Burbano, MJ
    Archer, H
    Rodriguez, M
    Shor-Posner, G
    [J]. AIDS, 2003, 17 (01) : 140 - 141
  • [9] Discontinuation of secondary prophylaxis for Pneumocystis pneumonia in human immunodeficiency virus-infected children treated with highly active antiretroviral therapy
    Esposito, S
    Bojanin, J
    Porta, A
    Cesati, L
    Gualtieri, L
    Principi, N
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2005, 24 (12) : 1117 - 1120
  • [10] Safe discontinuation of primary Pneumocystis prophylaxis in southern Indian HIV-infected patients on highly active antiretroviral therapy
    Kumarasamy, N
    Vallabhaneni, S
    Cecelia, AJ
    Mayer, KH
    Solomon, S
    Carpenter, CCJ
    Flanigan, TP
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005, 40 (03) : 377 - 378
12345